MetLife stock trades near yearly high as earnings and buybacks support valuation
Published on 07/18/2026 at 17:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
MetLife Inc. (ISIN US59156R1086), a leading US insurance and financial services group listed on the New York Stock Exchange, has seen MetLife stock move toward the upper end of its recent trading range, supported by earnings growth and ongoing share repurchases as of 18 July 2026.
MetLife revenue tops USD 69 billion
According to the companys latest annual report for fiscal 2025, MetLife generated total revenue of approximately USD 69.3 billion, reflecting modest growth compared with the preceding year when revenue was around USD 67.8 billion. This implies an increase of roughly USD 1.5 billion year over year, underlining the groups ability to expand its top line in a mixed macroeconomic and interest-rate environment.
Net income attributable to MetLife common shareholders in fiscal 2025 was reported in the region of USD 4.8 billion, compared with about USD 3.9 billion in fiscal 2024, indicating profit growth of close to USD 0.9 billion year over year. The earnings expansion was driven by both underwriting performance and higher investment income, as rising interest rates supported yields on MetLife’s fixed income portfolio while disciplined pricing supported margins in key insurance segments.
EPS growth and capital return strategy
Measured per share, MetLife reported diluted earnings per share for fiscal 2025 in the area of USD 7.00, up from roughly USD 5.70 in fiscal 2024. This represents EPS growth of about 22.8%, a pace that outstripped the underlying revenue growth as operating leverage and capital efficiency supported shareholder returns. The improvement in EPS reflects not only the higher net income but also ongoing share repurchases, which reduced the average number of shares outstanding.
The company has been returning cash to shareholders through a combination of dividends and buybacks. For fiscal 2025, MetLife paid an annualized dividend of around USD 2.08 per share, which marked an increase from approximately USD 1.92 per share in fiscal 2024, a rise of about 8.3%. In parallel, the group executed share repurchases amounting to roughly USD 3.0 billion in fiscal 2025, following buybacks of about USD 2.5 billion in fiscal 2024. The increased capital return underscores managements confidence in the balance sheet and earnings trajectory.
The dividend yield based on an indicative MetLife stock price in the high USD 60s remains in the mid-single-digit range, offering income-focused investors a combination of yield and potential for dividend growth. With share repurchases reducing the share count, the capital return strategy has magnified the impact of earnings on EPS while providing a partial buffer against market volatility.
MetLife stock near 52-week high around USD 72
In equity market terms, MetLife stock has been trading close to its 52-week high. As of 18 July 2026, the shares are observed around USD 72 on the New York Stock Exchange, compared with a 52-week low near USD 54. This places the stock roughly 33% above its low over the period, indicating that investors have rewarded the companys improved earnings profile and capital return framework. The current level is only a few dollars below the recent 52-week high, suggesting that the market is pricing in sustained profitability and stable credit quality.
At a price near USD 72, MetLife’s implied market capitalization stands in the region of USD 51 billion, assuming a share count just above 700 million. This valuation reflects a price-to-earnings multiple of roughly 10.3 times the fiscal 2025 diluted EPS of around USD 7.00. Compared with historical averages for large US life insurers, this multiple sits in a moderate range that balances earnings growth prospects against sector cyclicality and regulatory capital requirements.
In relative performance terms, MetLife stock has delivered a solid return over the last twelve months, outpacing some traditional fixed income benchmarks that form part of institutional portfolios. While the shares have not matched the strongest gains seen in high-growth technology names, the combination of dividend income, buybacks and earnings growth has positioned MetLife as a stable total-return component in diversified portfolios, particularly for investors seeking exposure to insurance and retirement services.
Read-more and investor relations
Further details on MetLife fundamentals
Investors who want to explore MetLife’s latest filings, guidance, and detailed segment performance can use the issuer-specific overview and the company’s own investor relations materials.
US Group Benefits segment supports growth
A key contributor to MetLife’s recent performance has been its US Group Benefits segment, which offers life, dental, disability, and other employee benefits products to corporate and institutional clients. In fiscal 2025, this segment generated revenue of roughly USD 23.5 billion, compared with about USD 22.1 billion in fiscal 2024, translating into revenue growth of nearly 6.3%. The expansion reflects both new business wins and retention of existing accounts, as employers continue to prioritize comprehensive benefits offerings in a competitive labor market.
Operating earnings in the US Group Benefits segment for fiscal 2025 were reported in the area of USD 3.0 billion, slightly ahead of the approximately USD 2.7 billion achieved in fiscal 2024. This earnings growth of around 11.1% year over year stems from improved underwriting margin and scale effects as MetLife optimized administrative processes and digital channels. The margins in group benefits are particularly important because they help offset volatility in more interest rate sensitive segments.
Beyond group benefits, MetLife’s Retirement and Income Solutions business has leveraged higher rates to offer more attractive annuity and pension risk transfer products. In fiscal 2025, revenue in this area was near USD 16.0 billion, up from roughly USD 14.5 billion in fiscal 2024, a rise of about 10.3%. The segment’s growth illustrates how MetLife is capitalizing on institutional demand to transfer long-term pension obligations, reinforcing its role as a key player in the US retirement landscape.
Balance sheet strength and risk profile
The company’s balance sheet underpins its ability to absorb shocks and continue capital distribution. MetLife reported total assets of approximately USD 700 billion at the end of fiscal 2025, compared with around USD 690 billion at the end of fiscal 2024. On the liability side, insurance contract liabilities and policyholder reserves remain substantial, reflecting long-duration commitments that require careful asset-liability management.
Shareholders equity attributable to MetLife common shareholders stood near USD 40 billion at the fiscal 2025 year-end, up from roughly USD 38 billion a year earlier. This increase of about USD 2 billion reflects retained earnings after dividend payments and the impact of mark-to-market adjustments on the investment portfolio. Regulatory capital ratios across key insurance entities remained above required minimums, providing further assurance that MetLife can sustain its insurance obligations under stress scenarios.
The investment portfolio remains heavily weighted toward high-quality fixed income securities, including corporate and government bonds. In fiscal 2025, net investment income was approximately USD 25.0 billion, compared with about USD 23.0 billion in fiscal 2024, a gain of roughly 8.7%. Higher yields and prudent credit selection contributed to this outcome, supporting MetLife’s capacity to fund claims and obligations while delivering returns aligned with its risk appetite.
MetLife stock and long-term investor perspectives
For long-term investors, MetLife stock offers exposure to a diversified set of insurance and financial products that are linked to demographic and economic trends such as aging populations, employer-sponsored benefits, and retirement savings. The company’s ability to generate stable cash flows from premiums and investment income, combined with prudent capital allocation, underpins its investment case in the broader financials sector.
From a valuation standpoint, the current price-to-book ratio for MetLife, based on a share price near USD 72 and shareholders equity per share in the region of USD 57, is around 1.26 times. This indicates that the market is assigning a modest premium to the book value, reflecting expectations of continued earnings growth, disciplined risk management, and the potential for further capital returns. Compared with some peers in the US life insurance industry that trade closer to book value, MetLife’s premium suggests that investors view its franchise and earnings quality favorably.
Analysts covering the insurance sector often highlight MetLife’s scale and diversification as key strengths. While consensus estimates vary, a mid-teens percentage return on equity target over the medium term is often cited as a sign of management’s ambition to maintain a competitive performance level. If MetLife can sustain EPS growth near the mid-teens and maintain its dividend growth trajectory, the stock may remain a useful component for investors seeking both income and moderate capital appreciation, subject to individual risk tolerance and portfolio strategy.
MetLife product footprint and customer reach
MetLife’s product portfolio spans individual life insurance, annuities, retirement solutions, and a broad range of group benefits. The company serves millions of customers worldwide, providing protection and savings products that are often embedded in employer-sponsored benefit programs or sold through financial advisors. In the US, MetLife is particularly well known for its group life and dental offerings, which form a core part of its employer relationships.
The focus on digital channels and self-service tools has expanded the reach of MetLife’s products. The company has invested in online enrollment platforms, mobile apps, and data analytics to streamline customer onboarding and claims management. These investments aim to reduce operating costs and improve user experience, which can bolster client retention and support cross-selling opportunities across the product suite.
MetLife stock price and recent trading context
MetLife stock, traded on the NYSE under the symbol MET, is observed around USD 72 as of 18 July 2026. This level compares with an approximate year-to-date entry point near USD 64 at the beginning of 2026, suggesting an increase of roughly 12.5% over the period. The year-to-date gain reflects the market’s response to the fiscal 2025 results and management’s guidance for the current year, alongside the broader performance of US financials in an environment of normalized interest rates.
Intraday trading volumes for MetLife stock typically range around 3 million to 4 million shares on standard trading days, underlining solid liquidity that allows institutional and retail investors to adjust positions without substantial market impact under normal conditions. The combination of liquidity, dividend income, and earnings growth has made MetLife a frequently cited name in financial sector portfolios.
MetLife key market data
- Company: MetLife Inc.
- ISIN: US59156R1086
- Ticker: NYSE: MET
- Trading venue: NYSE
- Price (as of 18 July 2026, 15:30 UTC): 72.00 USD
- Market capitalization: 51.0 billion USD (as of 18 July 2026)
- Sector / Industry: Financials / Insurance
- Index membership: S&P 500
- Next earnings date: 2 August 2026
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
